Percutaneous Needle Tenotomy (PNT) Versus Platelet Rich Plasma (PRP) With PNT in the Treatment of Chronic Tendinosis
Primary Purpose
Chronic Tendinopathy
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
PNT + PRP
PNT alone
Sponsored by
About this trial
This is an interventional treatment trial for Chronic Tendinopathy focused on measuring Chronic tendinopathy, platelet rich plasma, tendonitis, percutaneous tendon tenotomy, pain, shoulder, knee, ankle, foot
Eligibility Criteria
Inclusion Criteria:
- aged 18-100 years
- pain (≥ 5/10 pain on the VAS) that is a direct result of tendinosis as determined by history of injury and study team member physician's best judgment and review of medical records, imaging studies, etc.
- Tendinosis will be confirmed by clinical and ultrasonographic examination by the PI
- ≥3 months of pain after injury that has failed conservative treatments or after corticosteroid (CSI) (must be 3 months after CSI to avoid theoretical tendon rupture)
Exclusion Criteria:
- taking coumadin or other anti-coagulant or anti-platelet medication
- known coagulopathy or bleeding dyscrasia
- current or recent fluoroquinolone prescription
- prior PNT or PRP for the affected tendon(s)
- known systemic illness such as vasculitis, an autoimmune or an inflammatory disease, or uncontrolled diabetes
- presence of other musculoskeletal injury or tendon rupture in the region
currently are or plan to become pregnant during the study.
- Patients taking aspirin or NSAIDs are not excluded.
Sites / Locations
- Hospital for Special Surgery
- Department of Rehabilitation Medicine, Icahn School of Medicine at Mount Sinai
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
PNT + PRP
PNT alone
Arm Description
percutaneous needle tenotomy with peritendinous platelet-rich plasma injection
percutaneous needle tenotomy alone
Outcomes
Primary Outcome Measures
Improvement in pain based on a visual analog score
Improvement in pain based on a visual analog score
Improvement in pain based on a visual analog score
Improvement in pain based on a visual analog score
Improvement in pain based on a visual analog score
Secondary Outcome Measures
Activity Level
Function, sleep, general well-being, return to normal activities, work, sports and reduction in pain medication usage.
Activity Level
Function, sleep, general well-being, return to normal activities, work, sports and reduction in pain medication usage.
Activity Level
Function, sleep, general well-being, return to normal activities, work, sports and reduction in pain medication usage.
Activity Level
Function, sleep, general well-being, return to normal activities, work, sports and reduction in pain medication usage.
Activity Level
Function, sleep, general well-being, return to normal activities, work, sports and reduction in pain medication usage.
Complications
bleeding, infection, tendon rupture, allergic reaction, paralysis, or stroke
Complications
bleeding, infection, tendon rupture, allergic reaction, paralysis, or stroke
Complications
bleeding, infection, tendon rupture, allergic reaction, paralysis, or stroke
Complications
bleeding, infection, tendon rupture, allergic reaction, paralysis, or stroke
Complications
bleeding, infection, tendon rupture, allergic reaction, paralysis, or stroke
Full Information
NCT ID
NCT01833598
First Posted
April 12, 2013
Last Updated
December 22, 2020
Sponsor
Hospital for Special Surgery, New York
1. Study Identification
Unique Protocol Identification Number
NCT01833598
Brief Title
Percutaneous Needle Tenotomy (PNT) Versus Platelet Rich Plasma (PRP) With PNT in the Treatment of Chronic Tendinosis
Official Title
The Efficacy of Ultrasound Guided Percutaneous Needle Tenotomy (PNT) Versus Platelet Rich Plasma (PRP) With PNT in the Treatment of Chronic Tendinosis
Study Type
Interventional
2. Study Status
Record Verification Date
November 2020
Overall Recruitment Status
Completed
Study Start Date
September 2012 (Actual)
Primary Completion Date
June 2019 (Actual)
Study Completion Date
June 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospital for Special Surgery, New York
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Tendinopathy is a clinical syndrome of chronic pain and tendon degeneration that impairs a person's ability to perform daily activities and recreation. Traditional conservative treatments include activity modification, exercises, ice/heat, and medications and corticosteroid injection. A newer treatment is percutaneous needle tenotomy (PNT), in which the affected area is repetitively needled to disrupt pathological tissue and induce bleeding. This turns a nonhealing chronic injury into an acute injury with enhanced healing capability. Another is Platelet Rich Plasma (PRP), whereby patients' own platelets are injected into the affected area, also activating growth factors. There has been promising research in these tendinopathy treatments but more research is needed.
The investigators plan to expand on prior studies to identify a reproducible and efficacious treatment for chronic tendinopathy to reduce pain and improve function and quality of life. Our goal in this study is to assess the efficacy of ultrasound guided (USG) PNT versus PNT with peritendinous PRP as a treatment for chronic tendinopathy.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Tendinopathy
Keywords
Chronic tendinopathy, platelet rich plasma, tendonitis, percutaneous tendon tenotomy, pain, shoulder, knee, ankle, foot
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
40 (Actual)
8. Arms, Groups, and Interventions
Arm Title
PNT + PRP
Arm Type
Active Comparator
Arm Description
percutaneous needle tenotomy with peritendinous platelet-rich plasma injection
Arm Title
PNT alone
Arm Type
Active Comparator
Arm Description
percutaneous needle tenotomy alone
Intervention Type
Procedure
Intervention Name(s)
PNT + PRP
Other Intervention Name(s)
percutaneous needle tenotomy with peritendinous platelet-rich plasma injection
Intervention Description
The PNT + PRP group will undergo needle tenotomy under direct and continuous ultrasound guidance with even distribution of PRP into the peritendinous area(s) of PNT around the affected tendon.
Intervention Type
Procedure
Intervention Name(s)
PNT alone
Other Intervention Name(s)
percutaneous needle tenotomy alone
Intervention Description
The PNT group will undergo needle tenotomy under direct and continuous ultrasound guidance local anesthesia into the affected tendon. 10 minutes after the injection, the ultrasound machine probe will be passed over the areas treated both to evaluate for any structural changes and for any complications.
Primary Outcome Measure Information:
Title
Improvement in pain based on a visual analog score
Time Frame
Week 2
Title
Improvement in pain based on a visual analog score
Time Frame
Week 4
Title
Improvement in pain based on a visual analog score
Time Frame
Week 6
Title
Improvement in pain based on a visual analog score
Time Frame
Week 8
Title
Improvement in pain based on a visual analog score
Time Frame
Week 12
Secondary Outcome Measure Information:
Title
Activity Level
Description
Function, sleep, general well-being, return to normal activities, work, sports and reduction in pain medication usage.
Time Frame
Week 2
Title
Activity Level
Description
Function, sleep, general well-being, return to normal activities, work, sports and reduction in pain medication usage.
Time Frame
Week 4
Title
Activity Level
Description
Function, sleep, general well-being, return to normal activities, work, sports and reduction in pain medication usage.
Time Frame
Week 6
Title
Activity Level
Description
Function, sleep, general well-being, return to normal activities, work, sports and reduction in pain medication usage.
Time Frame
Week 8
Title
Activity Level
Description
Function, sleep, general well-being, return to normal activities, work, sports and reduction in pain medication usage.
Time Frame
Week 12
Title
Complications
Description
bleeding, infection, tendon rupture, allergic reaction, paralysis, or stroke
Time Frame
Week 2
Title
Complications
Description
bleeding, infection, tendon rupture, allergic reaction, paralysis, or stroke
Time Frame
Weeks 4
Title
Complications
Description
bleeding, infection, tendon rupture, allergic reaction, paralysis, or stroke
Time Frame
Weeks 6
Title
Complications
Description
bleeding, infection, tendon rupture, allergic reaction, paralysis, or stroke
Time Frame
Weeks 8
Title
Complications
Description
bleeding, infection, tendon rupture, allergic reaction, paralysis, or stroke
Time Frame
Weeks 12
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
aged 18-100 years
pain (≥ 5/10 pain on the VAS) that is a direct result of tendinosis as determined by history of injury and study team member physician's best judgment and review of medical records, imaging studies, etc.
Tendinosis will be confirmed by clinical and ultrasonographic examination by the PI
≥3 months of pain after injury that has failed conservative treatments or after corticosteroid (CSI) (must be 3 months after CSI to avoid theoretical tendon rupture)
Exclusion Criteria:
taking coumadin or other anti-coagulant or anti-platelet medication
known coagulopathy or bleeding dyscrasia
current or recent fluoroquinolone prescription
prior PNT or PRP for the affected tendon(s)
known systemic illness such as vasculitis, an autoimmune or an inflammatory disease, or uncontrolled diabetes
presence of other musculoskeletal injury or tendon rupture in the region
currently are or plan to become pregnant during the study.
Patients taking aspirin or NSAIDs are not excluded.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jonathan Kirschner, MD
Organizational Affiliation
Hospital for Special Surgery, New York
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital for Special Surgery
City
New York
State/Province
New York
ZIP/Postal Code
10021
Country
United States
Facility Name
Department of Rehabilitation Medicine, Icahn School of Medicine at Mount Sinai
City
New York
State/Province
New York
ZIP/Postal Code
10029
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
24149868
Citation
Kaux JF, Forthomme B, Goff CL, Crielaard JM, Croisier JL. Current opinions on tendinopathy. J Sports Sci Med. 2011 Jun 1;10(2):238-53.
Results Reference
background
PubMed Identifier
16934204
Citation
Scott A, Ashe MC. Common tendinopathies in the upper and lower extremities. Curr Sports Med Rep. 2006 Sep;5(5):233-41. doi: 10.1097/01.csmr.0000306421.85919.9c.
Results Reference
background
PubMed Identifier
18294189
Citation
Fredberg U, Stengaard-Pedersen K. Chronic tendinopathy tissue pathology, pain mechanisms, and etiology with a special focus on inflammation. Scand J Med Sci Sports. 2008 Feb;18(1):3-15. doi: 10.1111/j.1600-0838.2007.00746.x.
Results Reference
background
PubMed Identifier
14977675
Citation
Struijs PA, Kerkhoffs GM, Assendelft WJ, Van Dijk CN. Conservative treatment of lateral epicondylitis: brace versus physical therapy or a combination of both-a randomized clinical trial. Am J Sports Med. 2004 Mar;32(2):462-9. doi: 10.1177/0095399703258714.
Results Reference
background
PubMed Identifier
20970844
Citation
Coombes BK, Bisset L, Vicenzino B. Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: a systematic review of randomised controlled trials. Lancet. 2010 Nov 20;376(9754):1751-67. doi: 10.1016/S0140-6736(10)61160-9. Epub 2010 Oct 21.
Results Reference
background
PubMed Identifier
18645071
Citation
McShane JM, Shah VN, Nazarian LN. Sonographically guided percutaneous needle tenotomy for treatment of common extensor tendinosis in the elbow: is a corticosteroid necessary? J Ultrasound Med. 2008 Aug;27(8):1137-44. doi: 10.7863/jum.2008.27.8.1137.
Results Reference
background
PubMed Identifier
16998100
Citation
McShane JM, Nazarian LN, Harwood MI. Sonographically guided percutaneous needle tenotomy for treatment of common extensor tendinosis in the elbow. J Ultrasound Med. 2006 Oct;25(10):1281-9. doi: 10.7863/jum.2006.25.10.1281.
Results Reference
background
PubMed Identifier
19710216
Citation
Housner JA, Jacobson JA, Misko R. Sonographically guided percutaneous needle tenotomy for the treatment of chronic tendinosis. J Ultrasound Med. 2009 Sep;28(9):1187-92. doi: 10.7863/jum.2009.28.9.1187.
Results Reference
background
PubMed Identifier
22341021
Citation
Skjong CC, Meininger AK, Ho SS. Tendinopathy treatment: where is the evidence? Clin Sports Med. 2012 Apr;31(2):329-50. doi: 10.1016/j.csm.2011.11.003.
Results Reference
background
PubMed Identifier
21048180
Citation
Maffulli N, Longo UG, Denaro V. Novel approaches for the management of tendinopathy. J Bone Joint Surg Am. 2010 Nov 3;92(15):2604-13. doi: 10.2106/JBJS.I.01744.
Results Reference
background
PubMed Identifier
12512406
Citation
Paavola M, Kannus P, Jarvinen TA, Jarvinen TL, Jozsa L, Jarvinen M. Treatment of tendon disorders. Is there a role for corticosteroid injection? Foot Ankle Clin. 2002 Sep;7(3):501-13. doi: 10.1016/s1083-7515(02)00056-6.
Results Reference
background
PubMed Identifier
16882889
Citation
Bahr R, Fossan B, Loken S, Engebretsen L. Surgical treatment compared with eccentric training for patellar tendinopathy (Jumper's Knee). A randomized, controlled trial. J Bone Joint Surg Am. 2006 Aug;88(8):1689-98. doi: 10.2106/JBJS.E.01181.
Results Reference
background
PubMed Identifier
21402369
Citation
Nguyen RT, Borg-Stein J, McInnis K. Applications of platelet-rich plasma in musculoskeletal and sports medicine: an evidence-based approach. PM R. 2011 Mar;3(3):226-50. doi: 10.1016/j.pmrj.2010.11.007.
Results Reference
background
PubMed Identifier
21872551
Citation
Finnoff JT, Fowler SP, Lai JK, Santrach PJ, Willis EA, Sayeed YA, Smith J. Treatment of chronic tendinopathy with ultrasound-guided needle tenotomy and platelet-rich plasma injection. PM R. 2011 Oct;3(10):900-11. doi: 10.1016/j.pmrj.2011.05.015. Epub 2011 Aug 26.
Results Reference
background
PubMed Identifier
20068208
Citation
de Vos RJ, Weir A, van Schie HT, Bierma-Zeinstra SM, Verhaar JA, Weinans H, Tol JL. Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. JAMA. 2010 Jan 13;303(2):144-9. doi: 10.1001/jama.2009.1986.
Results Reference
background
PubMed Identifier
21602565
Citation
de Jonge S, de Vos RJ, Weir A, van Schie HT, Bierma-Zeinstra SM, Verhaar JA, Weinans H, Tol JL. One-year follow-up of platelet-rich plasma treatment in chronic Achilles tendinopathy: a double-blind randomized placebo-controlled trial. Am J Sports Med. 2011 Aug;39(8):1623-9. doi: 10.1177/0363546511404877. Epub 2011 May 21.
Results Reference
background
PubMed Identifier
19641918
Citation
Filardo G, Kon E, Della Villa S, Vincentelli F, Fornasari PM, Marcacci M. Use of platelet-rich plasma for the treatment of refractory jumper's knee. Int Orthop. 2010 Aug;34(6):909-15. doi: 10.1007/s00264-009-0845-7. Epub 2009 Jul 31.
Results Reference
background
PubMed Identifier
19380129
Citation
Kon E, Filardo G, Delcogliano M, Presti ML, Russo A, Bondi A, Di Martino A, Cenacchi A, Fornasari PM, Marcacci M. Platelet-rich plasma: new clinical application: a pilot study for treatment of jumper's knee. Injury. 2009 Jun;40(6):598-603. doi: 10.1016/j.injury.2008.11.026. Epub 2009 Apr 19.
Results Reference
background
PubMed Identifier
14760802
Citation
Naredo E, Cabero F, Beneyto P, Cruz A, Mondejar B, Uson J, Palop MJ, Crespo M. A randomized comparative study of short term response to blind injection versus sonographic-guided injection of local corticosteroids in patients with painful shoulder. J Rheumatol. 2004 Feb;31(2):308-14.
Results Reference
background
PubMed Identifier
17464615
Citation
Rutten MJ, Maresch BJ, Jager GJ, de Waal Malefijt MC. Injection of the subacromial-subdeltoid bursa: blind or ultrasound-guided? Acta Orthop. 2007 Apr;78(2):254-7. doi: 10.1080/17453670710013762.
Results Reference
background
PubMed Identifier
21705157
Citation
Wolf JM, Ozer K, Scott F, Gordon MJ, Williams AE. Comparison of autologous blood, corticosteroid, and saline injection in the treatment of lateral epicondylitis: a prospective, randomized, controlled multicenter study. J Hand Surg Am. 2011 Aug;36(8):1269-72. doi: 10.1016/j.jhsa.2011.05.014. Epub 2011 Jun 25.
Results Reference
background
PubMed Identifier
21406450
Citation
Creaney L, Wallace A, Curtis M, Connell D. Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single-blind, randomised trial of autologous blood injections versus platelet-rich plasma injections. Br J Sports Med. 2011 Sep;45(12):966-71. doi: 10.1136/bjsm.2010.082503. Epub 2011 Mar 15.
Results Reference
background
PubMed Identifier
19481375
Citation
Kaux JF, Le Goff C, Seidel L, Peters P, Gothot A, Albert A, Crielaard JM. [Comparative study of five techniques of preparation of platelet-rich plasma]. Pathol Biol (Paris). 2011 Jun;59(3):157-60. doi: 10.1016/j.patbio.2009.04.007. Epub 2009 May 28. French.
Results Reference
background
PubMed Identifier
12037247
Citation
Koh ES, Williams AJ, Povlsen B. Upper-limb pain in long-term poliomyelitis. QJM. 2002 Jun;95(6):389-95. doi: 10.1093/qjmed/95.6.389.
Results Reference
background
PubMed Identifier
33644963
Citation
Kirschner JS, Cheng J, Hurwitz N, Santiago K, Lin E, Beatty N, Kingsbury D, Wendel I, Milani C. Ultrasound-guided percutaneous needle tenotomy (PNT) alone versus PNT plus platelet-rich plasma injection for the treatment of chronic tendinosis: A randomized controlled trial. PM R. 2021 Dec;13(12):1340-1349. doi: 10.1002/pmrj.12583. Epub 2021 Apr 28.
Results Reference
derived
Learn more about this trial
Percutaneous Needle Tenotomy (PNT) Versus Platelet Rich Plasma (PRP) With PNT in the Treatment of Chronic Tendinosis
We'll reach out to this number within 24 hrs